Neuronetics (STIM) Announces Participation in B. Riley Summit and Leadership Appointment
Neuronetics, Inc. (NASDAQ: STIM) announced its participation at the B. Riley Mind, Muscle & Vision Summit on July 16, 2026, where it will join a panel discussion alongside Compass Pathways. The company also appointed Robert Greene as Senior Vice President of Sales and is set to present real-world data from its TrakStar database at the Clinical TMS Society Annual Meeting.
Topics: Neuropsychiatric Drugs Sales Leadership Change TMS (Transcranial Magnetic Stimulation)